TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28709418

Group type: EXPERIMENTAL
Intervention: Physically active individuals
Number of subjects: 72

Group type: COMPARATOR
Intervention: Non-physically active individuals
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Greater knee flexion
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Knee flexion
Number of subjects: 72
Study: 28709421

Group type: EXPERIMENTAL
Intervention: Health related quality of life measured by St George's Respiratory Questionnaire (SGRQ)
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Health related quality of life measured by UCSD Shortness-of-Breath Questionnaire (SoB)
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Health related quality of life measured by EuroQol visual analogue scale (EQ-5D VAS)
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Health related quality of life measured by Well-being Index (WHO-5)
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Multivariate analysis of QoL (by SGRQ total)
Number of subjects: 623
Study: 28709439

Group type: EXPERIMENTAL
Intervention: Enhanced antimicrobial de-escalation (EAD)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Routine antibiotic management (RAM)
Number of subjects: 283
Study: 28709774

Group type: EXPERIMENTAL
Intervention: Cardio-respiratory fitness (CRF)
Number of subjects: 80
Study: 28710110

Group type: EXPERIMENTAL
Intervention: Patient-tailored complementary/integrative medicine (CIM) programme, with adherence defined as attending ≥4 CIM treatments, with ≤30 days between each session.
Number of subjects: 388

Group type: COMPARATOR
Intervention: Standard supportive care (Control group).
Number of subjects: 388
Study: 28710215

Group type: EXPERIMENTAL
Intervention: EEG, blood work (biomarkers; gene studies), sleep study (actigraphy), questionnaires, neuropsychological testing at 12 months follow-up
Number of subjects: 0
Study: 28710330

Group type: EXPERIMENTAL
Intervention: Intracerebral hemorrhage (ICH) patients
Number of subjects: 2074
Study: 28710563

Group type: EXPERIMENTAL
Intervention: Morphine administered intravenously
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: IL-6 concentrations measured preoperatively, during surgery, and postoperatively
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Open surgical group
Number of subjects: 33
Study: 28710747

Group type: EXPERIMENTAL
Intervention: CART-HER2 cells infused after conditioning treatment with nab-paclitaxel (100-200 mg/m2)
Number of subjects: 0
Study: 28711173

Group type: EXPERIMENTAL
Intervention: RT-PCR assay for SMN1 deletion
Number of subjects: 120267

Group type: EXPERIMENTAL
Intervention: DBS ddPCR screening assay
Number of subjects: 120267

Group type: EXPERIMENTAL
Intervention: Incidence of SMA
Number of subjects: 120267

Group type: EXPERIMENTAL
Intervention: Diagnosis of SMA
Number of subjects: 120267

Group type: EXPERIMENTAL
Intervention: Newborn screening
Number of subjects: 120267

Group type: EXPERIMENTAL
Intervention: Combination of RT-PCR and ddPCR
Number of subjects: 120267
Study: 28711743

Group type: EXPERIMENTAL
Intervention: SIMPLe 1.0 smartphone application
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: SIMPLe 1.0 smartphone application (completers)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: SIMPLe 1.0 smartphone application (after ANCOVA)
Number of subjects: 51
Study: 28712102

Group type: EXPERIMENTAL
Intervention: Ziv-aflibercept
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ramucirumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuation of first-line bevacizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidermal growth factor receptor (EGFR)-directed therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel biomarkers (BRAF, HER2, mismatch repair deficiency)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel combination strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New biologic therapies with novel targets
Number of subjects: 0
Study: 28712360

Group type: EXPERIMENTAL
Intervention: P. falciparum infections in HIV-uninfected Mozambican women
Number of subjects: 1714

Group type: EXPERIMENTAL
Intervention: P. falciparum infections in HIV-uninfected Gabonese women
Number of subjects: 1714

Group type: EXPERIMENTAL
Intervention: P. falciparum infections in HIV-uninfected Beninese women
Number of subjects: 1714

Group type: EXPERIMENTAL
Intervention: Past or chronic placental P. falciparum infection in Mozambican newborns
Number of subjects: 1714

Group type: EXPERIMENTAL
Intervention: Doubling qPCR-peripheral parasite densities in Mozambican women
Number of subjects: 1714

Group type: COMPARATOR
Intervention: HIV-infected women from Kenya
Number of subjects: 1714

Group type: COMPARATOR
Intervention: HIV-infected women from Mozambique
Number of subjects: 1714
Study: 28712533

Group type: EXPERIMENTAL
Intervention: 60Gy intensity modulated radiotherapy with concurrent weekly intravenous cisplatinum
Number of subjects: 43
Study: 28712602

Group type: EXPERIMENTAL
Intervention: Citrate (7.5mEq/kg per day)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Glutamine (400mg/kg per day)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Ornithine α-ketoglutarate (400mg/kg per day)
Number of subjects: 3
Study: 28712815

Group type: EXPERIMENTAL
Intervention: Asymptomatic carotid stenosis patients
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Asymptomatic carotid stenosis patients with reduced BHI
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control patients without stenosis
Number of subjects: 144
Study: 28713060

Group type: EXPERIMENTAL
Intervention: Endoscopic imaging using a standardized protocol (high-definition white light and narrow-band imaging)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Endoscopically designated non-dysplastic SSPs
Number of subjects: 83
Study: 28713062

Group type: EXPERIMENTAL
Intervention: Second-generation colon capsule endoscopy (CCE-2)
Number of subjects: 150
Study: 28713063

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA) of the gastric remnant pouch
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 25
Study: 28713256

Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study: 28713365

Group type: EXPERIMENTAL
Intervention: Detection and quantification of immune compounds in human milk
Number of subjects: 0
Study: 28713581

Group type: EXPERIMENTAL
Intervention: Elevated protein intake (EPI, 20% of daily calorie intake)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Recommended protein intake (RPI, 10% of daily calorie intake)
Number of subjects: 12
Study: 28713801

Group type: EXPERIMENTAL
Intervention: Train-the-trainer workshop (TTT)
Number of subjects: 56
Study: 28714866

Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 32

Group type: COMPARATOR
Intervention: Acalabrutinib
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 32
Study: 28714868

Group type: EXPERIMENTAL
Intervention: Vorinostat (VOR)
Number of subjects: 16
Study: 28716015

Group type: EXPERIMENTAL
Intervention: Health status assessment through medical examination, past medical history, haemoglobin concentration, HIV and malaria testing.
Number of subjects: 421
Study: 28716018

Group type: EXPERIMENTAL
Intervention: Automated analysis of cardiorespiratory signals prior to planned extubation.
Number of subjects: 250
Study: 28716049

Group type: EXPERIMENTAL
Intervention: DSM-5 criteria for AUD
Number of subjects: 304

Group type: COMPARATOR
Intervention: DSM-IV criteria for AUD
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Both DSM-IV and DSM-5 criteria for AUD
Number of subjects: 304

Group type: COMPARATOR
Intervention: Neither DSM-5 nor DSM-IV criteria for AUD
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: DSM-5 alone
Number of subjects: 304
Study: 28716065

Group type: EXPERIMENTAL
Intervention: SF-12 survey for physical component scores
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SF-12 survey for mental component scores
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HSUV measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AUC analysis
Number of subjects: 0
Study: 28716114

Group type: EXPERIMENTAL
Intervention: Visumax femtosecond laser (FSL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Moria M2 microkeratome (MK)
Number of subjects: 60
Study: 28716404

Group type: EXPERIMENTAL
Intervention: Incisionless magnetic anastomosis system (IMAS) for partial jejunal diversion (PJD)
Number of subjects: 10
Study: 28716771

Group type: EXPERIMENTAL
Intervention: Gamification intervention (Stick To It) including online enrollment, web-based activities (quizzes, reminders), and in-person activities at sexual health clinics.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Gamification intervention (Stick To It)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Historical control group (individuals meeting inclusion criteria who attended study clinics in the 12 months prior to intervention implementation)
Number of subjects: 60
Study: 28716784

Group type: EXPERIMENTAL
Intervention: Prehospital notification application used by ambulance clinicians
Number of subjects: 0
Study: 28716801

Group type: EXPERIMENTAL
Intervention: Renin-angiotensin-aldosterone blockade
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (ACR-ve diabetes mellitus patients and healthy controls)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: ACR+ve diabetes mellitus patients after 1-year treatment with renin-angiotensin-aldosterone blockade
Number of subjects: 130
Study: 28716862

Group type: EXPERIMENTAL
Intervention: Autologous gene therapy using a self-inactivating lentiviral vector (LV-w1.6 WASp) after reduced-intensity conditioning
Number of subjects: 1
Study: 28716981

Group type: EXPERIMENTAL
Intervention: Follow-up noncontrast CT imaging
Number of subjects: 242

Group type: COMPARATOR
Intervention: Baseline variables alone
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Poor recanalization on CTA
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Poor reperfusion on CTP
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Unfavorable outcome defined as modified Rankin Scale 3 to 6
Number of subjects: 242
Study: 28716989

Group type: EXPERIMENTAL
Intervention: Multisite FMD (string-of-beds or focal stenoses affecting at least 2 vascular beds)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Single-site disease with dissections or aneurisms
Number of subjects: 469

Group type: COMPARATOR
Intervention: Cerebrovascular presentation with hypertension
Number of subjects: 469

Group type: COMPARATOR
Intervention: Renal presentation with bilateral RA lesions
Number of subjects: 469
Study: 28717036

Group type: EXPERIMENTAL
Intervention: Health care workers (HCWs) wearing gowns and gloves (G&G) during usual care activities.
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Type of care provided by HCWs.
Number of subjects: 185
Study: 28717404

Group type: EXPERIMENTAL
Intervention: 150 min per week of aerobic physical activity
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 300 min per week of aerobic physical activity
Number of subjects: 400
Study: 28717512

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy for PTSD (DBT-PTSD)
Number of subjects: 23
Study: 28717516

Group type: EXPERIMENTAL
Intervention: Intravenous Darbepoetin (DA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous Epoetin (EPO)
Number of subjects: 50
Study: 28718100

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass (CPB) exposure for 142 min
Number of subjects: 2280

Group type: COMPARATOR
Intervention: No CPB exposure
Number of subjects: 2280
Study: 28718760

Group type: EXPERIMENTAL
Intervention: Decitabine and plerixafor
Number of subjects: 0
Study: 28719029

Group type: EXPERIMENTAL
Intervention: Sofosbuvir + peginterferon alfa 2a + ribavirin (SOF+PR) for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sofosbuvir + ribavirin (SOF+R) for 24 weeks
Number of subjects: 50
Study: 28719225

Group type: EXPERIMENTAL
Intervention: Structural social support (living with others, having a caregiver)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Functional social support (measured with the Medical Outcomes Social Support Survey)
Number of subjects: 282
Study: 28719496

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 200
Study: 28719502

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM vaccine
Number of subjects: 387
Study: 28719652

Group type: EXPERIMENTAL
Intervention: HIVconsv vaccine (plasmid DNA, simian adenovirus, poxvirus MVA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HIVconsv vaccine
Number of subjects: 12
Study: 28720095

Group type: EXPERIMENTAL
Intervention: Circulating fibrocytes measurement using a modified faster method without intracellular staining.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional culture method for measuring mature fibrocytes in vitro.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 28720129

Group type: EXPERIMENTAL
Intervention: RTW-focused approach in therapy
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Baseline work ability and expectancy of future work ability, history of psychiatric treatment, focus on RTW in treatment
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Improvement in expectations of future work ability at post-treatment
Number of subjects: 164
Study: 28720370

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 28720549

Group type: EXPERIMENTAL
Intervention: Adenoviral vectors injected into the resection cavity or remaining tumor (one expressing HSV-1 thymidine kinase and the other expressing Flt3L).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adenoviral vector expressing Flt3L.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HSV-1/ganciclovir treatment.
Number of subjects: 0
Study: 28720557

Group type: EXPERIMENTAL
Intervention: Customized text messaging
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Mobile app
Number of subjects: 225

Group type: COMPARATOR
Intervention: Website-control
Number of subjects: 225
Study: 28721051

Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 26
Study: 28721067

Group type: EXPERIMENTAL
Intervention: 80 mg pasireotide long-acting release (LAR) i.m.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 120 mg pasireotide long-acting release (LAR) i.m.
Number of subjects: 29
Study: 28721080

Group type: EXPERIMENTAL
Intervention: Broad-spectrum antibiotic therapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard antibiotic therapy
Number of subjects: 84
Study: 28721449

Group type: EXPERIMENTAL
Intervention: Regulatory T cells (Tregs)
Number of subjects: 0
Study: 28723307

Group type: EXPERIMENTAL
Intervention: Collection of longitudinal patient-reported outcomes (PROs)
Number of subjects: 21758

Group type: EXPERIMENTAL
Intervention: Consent to receive information on new interventional studies and possible participation in cohort multiple randomized controlled trials (cmRCTs)
Number of subjects: 21758
Study: 28724134

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD) therapy
Number of subjects: 1273

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1273

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 1273
Study: 28724373

Group type: EXPERIMENTAL
Intervention: Focus Groups (FG) and Key Informant Interviews (KI) with hospital staff
Number of subjects: 133
Study: 28724380

Group type: EXPERIMENTAL
Intervention: Access to and use of cell phones in the bedroom during the hour before sleep
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Access to and use of computers in the bedroom during the hour before sleep
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Access to and use of TVs in the bedroom during the hour before sleep
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Use of cell phones during the hour before sleep
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Use of computers during the hour before sleep
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Access to and use of TVs, cell phones, tablets, and video games in the bedroom
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Access to and use of a TV and computer during the hour before sleep
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Rarely reading a printed book in the bedroom during the hour before sleep
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Having access to an EECD in the bedroom
Number of subjects: 2334

Group type: COMPARATOR
Intervention: Frequent reading of a printed book in the bedroom during the hour before sleep
Number of subjects: 2334
Study: 28724434

Group type: EXPERIMENTAL
Intervention: Bernese Pain Scale for Neonates (BPSN) assessment during heel sticks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Individual contextual factors (gestational age, gender, number of painful procedures)
Number of subjects: 100
Study: 28724445

Group type: EXPERIMENTAL
Intervention: Combined plasmapheresis (PE) and allogeneic mesenchymal stem cells transplantation (MSCT) therapy
Number of subjects: 14
Study: 28724513

Group type: EXPERIMENTAL
Intervention: Tailored, Web-based HIV prevention intervention (6-session program)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Attention-control condition (HIV/STI information from sex education websites)
Number of subjects: 180
Study: 28724646

Group type: EXPERIMENTAL
Intervention: Trimethylamine treatment, dosage and duration not specified
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 28724795

Group type: COMPARATOR
Intervention: LXA4 and 15-epi-LXA4 levels in bronchoalveolar lavage (BAL) fluid
Number of subjects: 69

Group type: COMPARATOR
Intervention: SAA levels in BAL fluid
Number of subjects: 69

Group type: COMPARATOR
Intervention: ALX receptor expression in BAL macrophages
Number of subjects: 69

Group type: COMPARATOR
Intervention: LXA4loSAAhi levels
Number of subjects: 69

Group type: COMPARATOR
Intervention: SAA and aliquots of LXA4loSAAhi BAL fluid
Number of subjects: 69
Study: 28725257

Group type: EXPERIMENTAL
Intervention: Breastfeeding relaxation therapy (daily audio recording during breastfeeding)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no relaxation therapy)
Number of subjects: 0
Study: 28725451

Group type: EXPERIMENTAL
Intervention: WheelSeeU (peer-led wheelchair training program)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 28725452

Group type: EXPERIMENTAL
Intervention: MapMySmoke app
Number of subjects: 8
Study: 28725594

Group type: EXPERIMENTAL
Intervention: Weekly infusions of ascorbic acid (AA); week 1: 5 g, week 2: 30 g, weeks 3-12: 60 g
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Weekly infusions of ascorbic acid (AA)
Number of subjects: 23
Study: 28726115

Group type: EXPERIMENTAL
Intervention: Moderate-to-severe CCA in non-dialysis patients (Ca group)
Number of subjects: 1546

Group type: COMPARATOR
Intervention: None-to-mild CCA in non-dialysis patients (non-Ca group)
Number of subjects: 1546

Group type: EXPERIMENTAL
Intervention: Moderate-to-severe CCA in dialysis patients (Ca group)
Number of subjects: 1546

Group type: COMPARATOR
Intervention: None-to-mild CCA in dialysis patients (non-Ca group)
Number of subjects: 1546
Study: 28727542

Group type: EXPERIMENTAL
Intervention: US-guided high-intensity focused ultrasound (HIFU) ablation
Number of subjects: 30
Study: 28727583

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine and bupivacaine HCl mixture (266 mg liposomal bupivacaine and 125 mg 0.25% bupivacaine HCl with epinephrine 1:300,000)
Number of subjects: 40
Study: 28728650

Group type: EXPERIMENTAL
Intervention: Resolute Onyx 2.0-mm zotarolimus-eluting stent
Number of subjects: 101
Study: 28728652

Group type: EXPERIMENTAL
Intervention: Site-reported FFR measurements
Number of subjects: 763

Group type: COMPARATOR
Intervention: CL-analyzed FFR measurements
Number of subjects: 763

Group type: COMPARATOR
Intervention: Tracings with signal drift
Number of subjects: 763

Group type: COMPARATOR
Intervention: Tracings with waveform artifacts
Number of subjects: 763

Group type: COMPARATOR
Intervention: Predictors of distorted waveforms
Number of subjects: 763
Study: 28728686

Group type: EXPERIMENTAL
Intervention: Pregnancy-associated spontaneous coronary artery dissection (P-SCAD)
Number of subjects: 323
Study: 28728751

Group type: EXPERIMENTAL
Intervention: Brivanib 800mg orally every day (1 cycle = 28 days) until disease progression or prohibitive toxicity
Number of subjects: 28
Study: 28728924

Group type: EXPERIMENTAL
Intervention: Strabismus video goggles
Number of subjects: 41

Group type: COMPARATOR
Intervention: Hess screen test
Number of subjects: 41
Study: 28729326

Group type: EXPERIMENTAL
Intervention: CSDD (Cornell Scale for Depression in Dementia)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: BBS (Berg Balance Scale)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: 30 s CST (Chair Stand Test)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Walking speed (6-metre walking test)
Number of subjects: 170
Study: 28729911

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (VP)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 140
Study: 28730692

Group type: EXPERIMENTAL
Intervention: Cross-sex hormone therapy (CSHT) for trans men
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Cross-sex hormone therapy (CSHT) for trans women
Number of subjects: 183
Study: 28730932

Group type: EXPERIMENTAL
Intervention: Single-lumen tube (SLT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Double-lumen tube (DLT)
Number of subjects: 92
Study: 28731937

Group type: EXPERIMENTAL
Intervention: Operative management
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Nonoperative management
Number of subjects: 484
Study: 28732391

Group type: EXPERIMENTAL
Intervention: Intraductal radiofrequency ablation device
Number of subjects: 0
Study: 28732501

Group type: EXPERIMENTAL
Intervention: Peak CO exposure (≥4.1 ppm) in the 2 hours prior to BP measurement
Number of subjects: 44

Group type: COMPARATOR
Intervention: Improved cookstoves
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 24-h ABPM sessions
Number of subjects: 44
Study: 28733294

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (specific details not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational data collection (specific details not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microbiological tests (specific details not provided)
Number of subjects: 0